Selçuk Ecza Deposu Ticaret ve Sanayi A.S.

SELEC.IS

Medical - Distribution · Healthcare

Exchange

Istanbul Stock Exchange

Winston Score

Winston is serious

Below-average fundamentals — multiple weak pillars.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Weak

Growth

Good

Cash Flow

Weak

Stability

Good

Valuation

Weak

Track this stock — start free trial

Winston Score History

The full picture

Selçuk Ecza Deposu is one of Turkey's largest pharmaceutical wholesalers. It buys medicines, medical supplies, and healthcare products from manufacturers and distributes them to pharmacies, hospitals, and clinics across Turkey. The company sits in the middle of the healthcare supply chain, connecting drug makers to the places where patients actually get their medications.

The company makes money by buying products in bulk and reselling them at a small markup, which explains the thin margins typical of distribution businesses. It operates almost entirely within Turkey, making its financial performance closely tied to the Turkish economy, currency fluctuations, and government drug pricing policies. Its scale and established logistics network give it a competitive edge over smaller rivals, but the main risk is that Turkey's government regularly sets or adjusts the prices pharmacies and distributors can charge for medicines, which puts constant pressure on already narrow profit margins.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+48.0% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

+265.4% YoY

YoY Growth Rate

Strong earnings growth

Insider Activity

85.1%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

14.5B TRY cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Revenue accelerating

Selçuk Ecza Deposu Ticaret ve Sanayi A.S. grew revenue 48% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

11.2%

Thin — 11.2% gross margin

Profit after running costs

Operating Margin

5.3%

Thin — 5.3% operating margin

Return on the money invested

ROCE

11.1%

Below par — 11.1% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+37.8%

Fast-growing sales (+37.8% YoY)

Profit growth

EPS YoY

+56.7%

Earnings growing fast (+56.7% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is

EPS Consistency

3/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

-107%

Weak — only -107% of profit becomes cash

Spare cash per sale

FCF Margin

-1.6%

Burning cash (-1.6%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.72

Moderate — manageable debt (0.72)

Covers its interest

Interest Cover

7.32x

Adequate interest coverage (7.3x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

87.5x

no trend

Expensive — P/E 87.5

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial